By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Chiesi Farmaceutici SpA 

Via Palermo 26/ A

Parma    43100  Italy
Phone: 39-0521-279-230 Fax: 39-0521-774468



Company News
uniQure And Chiesi Farmaceutici SpA Announce Six Year Follow-up Data from Glybera® Treated Patients 3/17/2014 8:58:30 AM
Chiesi Farmaceutici SpA Completes Acquisition Of Cornerstone Therapeutics Inc. 2/4/2014 9:58:06 AM
Selvita Extends Long-Term Chemistry Collaboration With Chiesi Farmaceutici SpA 1/10/2014 10:12:55 AM
Chiesi Farmaceutici SpA to Buy Rest of Cornerstone Therapeutics Inc. for $255 Million 9/16/2013 6:52:01 AM
CereSpir Incorporated Announces Letter of Intent With Chiesi Farmaceutici SpA to License Worldwide Development and Commercialization Rights for CHF 5074 to CereSpir 7/26/2013 10:01:33 AM
CereSpir Incorporated is Pleased With Positive Interim Phase 2 Results for CHF 5074 in Patients With Mild Cognitive Impairment, Presented by Chiesi Farmaceutici SpA at the AAIC 2013 Meeting in Boston 7/26/2013 9:53:35 AM
uniQure, Chiesi Farmaceutici SpA Strike $58 Million Deal for Hemophilia B Development 7/9/2013 7:30:38 AM
Eddingpharm (Cayman) Inc. and Chiesi Farmaceutici SpA Form Asthma Drug JV 4/16/2013 9:08:36 AM
Cornerstone Therapeutics Inc. Acquires Exclusive U.S. Rights to Chiesi Farmaceutici SpA's BETHKIS® (Tobramycin Inhalation Solution) 11/8/2012 9:21:39 AM
Veloxis Pharmaceuticals A/S (VELO), Chiesi Farmaceutici SpA Ink $47.5 Million Pact 10/5/2012 7:02:49 AM